Described herein are pharmaceutical packaging programs which reduce oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate medicine, these kinds of methods including a syringe with an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with really low permeability to oxygen and